Published in Gene Therapy Weekly, October 4th, 2007
In May 2007, AVI announced that it had received the first three signed contracts valued at approximately $7.1 million from the Department of Defense (DoD) for the development of therapeutic drugs targeting Ebola virus...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.